{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:25:05Z","timestamp":1784031905977,"version":"3.55.0"},"reference-count":32,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"4","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005289","name":"National Institute of Justice","doi-asserted-by":"publisher","award":["3020-203"],"award-info":[{"award-number":["3020-203"]}],"id":[{"id":"10.13039\/100005289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can Pharm J"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mifepristone for medical abortion was first dispensed by community pharmacists in Canada directly to patients in January 2017. We asked about pharmacists\u2019 experiences over their first year dispensing mifepristone in order to evaluate the frequency of the new practice and assess availability in urban\/rural pharmacies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>From August to December 2019, we invited 433 community pharmacists who had completed a baseline survey at least 1 year prior to participate in a follow-up online survey. We summarized categorical data using counts and proportions and conducted a qualitative thematic analysis of open-ended responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 122 participants, 67.2% had dispensed the product, and 48.4% routinely stocked mifepristone. Pharmacists reported a mean of 26 and median of 3 (interquartile range, 1, 8) mifepristone prescriptions filled in their pharmacies in the previous year. Participants perceived that the benefits of making mifepristone available in pharmacies included increased abortion access for patients ( n = 115; 94.3%), reduced pressure on the health care system ( n = 104; 85.3%), increased rural and remote abortion access ( n = 103; 84.4%) and increased interprofessional collaborations ( n = 48; 39.3%). Few participants reported challenges to maintaining adequate stock of mifepristone, but these challenges included low demand ( n = 24; 19.7%), short expiry dating ( n = 12; 9.8%) and drug shortages ( n = 8; 6.6%). The overwhelming majority, 96.7%, reported that their communities did not resist the provision of mifepristone by their pharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation:<\/jats:title>\n                    <jats:p>Participating pharmacists reported many benefits and very few barriers to stocking and dispensing mifepristone. Both urban and rural communities responded positively to enhanced access to mifepristone in their community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Mifepristone is well accepted by pharmacists within the primary care system in Canada.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17151635231176270","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T01:40:01Z","timestamp":1686274801000},"page":"204-214","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Dispensing mifepristone for medical abortion in Canada: Pharmacists\u2019 experiences of the first year"],"prefix":"10.3138","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-5022","authenticated-orcid":false,"given":"Enav Z.","family":"Zusman","sequence":"first","affiliation":[{"name":"Contraception and Abortion Research Team of the Women\u2019s Health Research Institute, UBC, and of the Collaboration for Outcomes Research and Evaluation"},{"name":"Department of Obstetrics and Gynecology, University of British Columbia, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Munro","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of British Columbia, Vancouver"},{"name":"Centre for Health Evaluation and Outcome Sciences, Providence Health Care Research, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7882","authenticated-orcid":false,"given":"Wendy V.","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Family Practice, University of British Columbia, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-3223","authenticated-orcid":false,"given":"Judith A.","family":"Soon","sequence":"additional","affiliation":[{"name":"Contraception and Abortion Research Team of the Women\u2019s Health Research Institute, UBC, and of the Collaboration for Outcomes Research and Evaluation"},{"name":"Department of Family Practice, University of British Columbia, Vancouver"},{"name":"Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"bibr1-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2109779"},{"key":"bibr2-17151635231176270","unstructured":"MacKinnon B-J. Abortion pill now available for free to women in New Brunswick. CBC News, July 10, 2017. Available: https:\/\/www.cbc.ca\/news\/canada\/new-brunswick\/abortion-pill-mifegymiso-new-brunswick-free-1.4194436 (accessed Mar. 27, 2020)."},{"key":"bibr3-17151635231176270","unstructured":"Taylor S. \u201cEquity issue:\u201d Saskatchewan to fully cover cost of abortion drug Mifegymiso. The Canadian Press, June 7, 2019. Available: https:\/\/www.ctvnews.ca\/health\/equity-issue-saskatchewan-to-fully-cover-cost-of-abortion-drug-mifegymiso-1.4456532 (accessed Mar. 27, 2020)."},{"key":"bibr4-17151635231176270","unstructured":"CAPS CPCA. CAPS CPCA forum; 2020. Available: https:\/\/www.caps-cpca.ubc.ca\/index.php\/Main_Page (accessed Mar. 27, 2020)."},{"issue":"3","key":"bibr5-17151635231176270","volume":"154","author":"Rebic N","year":"2021","journal-title":"Can Pharm J Rev Pharm Can"},{"issue":"4","key":"bibr6-17151635231176270","volume":"154","author":"Rebi\u0107 N","year":"2021","journal-title":"Can Pharm J Rev Pharm Can"},{"key":"bibr7-17151635231176270","doi-asserted-by":"publisher","DOI":"10.2196\/34302"},{"key":"bibr8-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063370"},{"key":"bibr9-17151635231176270","doi-asserted-by":"crossref","unstructured":"Dillman DA, Smyth JD, Christian LM. Internet, phone, mail, and mixed-mode surveys: the tailored design method. 4th ed. Hoboken (NJ): John Wiley & Sons, Inc. 2014.","DOI":"10.1002\/9781394260645"},{"key":"bibr10-17151635231176270","volume-title":"Mail and internet surveys: the tailored design method","author":"Dillman D.","year":"2000"},{"key":"bibr11-17151635231176270","doi-asserted-by":"crossref","unstructured":"Norman WV, Munro S, Brooks M, et al. Could implementation of mifepristone address Canada\u2019s urban\u2013rural abortion access disparity: a mixed-methods implementation study protocol. BMJ Open 2019;9(4). Available: https:\/\/bmjopen.bmj.com\/content\/9\/4\/e028443 (accessed Dec. 26, 2019).","DOI":"10.1136\/bmjopen-2018-028443"},{"key":"bibr12-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-021-01144-w"},{"key":"bibr13-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-019-0520-8"},{"key":"bibr14-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2562"},{"key":"bibr15-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2020.1743825"},{"key":"bibr16-17151635231176270","unstructured":"Government of Canada SC. Focus on Geography Series, 2011 Census. 2012. Available: https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/as-sa\/fogs-spg\/select-Geo-Choix.cfm?Lang=Eng&GK=CMA&TOPIC=1 (accessed Mar. 3, 2020)."},{"key":"bibr17-17151635231176270","unstructured":"Research Data Capture REDCap. BCCHR. REDCap; 2014. Available: https:\/\/rc.bcchr.ca\/ (accessed May. 4, 2021)."},{"key":"bibr18-17151635231176270","doi-asserted-by":"crossref","unstructured":"Chun Tie Y, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. SAGE Open Med 2019;7. Available: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6318722\/ (accessed Jul. 6, 2020).","DOI":"10.1177\/2050312118822927"},{"key":"bibr19-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"bibr20-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1177\/1098214005283748"},{"key":"bibr21-17151635231176270","unstructured":"Canadian Pharmacists Association. Patient populations. Women\u2019s health; 2021. Available: https:\/\/www.pharmacists.ca\/advocacy\/practice-development-resources\/patient-populations\/ (accessed Dec. 16, 2021)."},{"key":"bibr22-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2021.06.017"},{"key":"bibr23-17151635231176270","doi-asserted-by":"crossref","unstructured":"Grossman D, Raifman S, Morris N, et al. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment. Contraception 2021;107:36-41. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S001078242100384X (accessed Dec. 12, 2021).","DOI":"10.1016\/j.contraception.2021.09.008"},{"key":"bibr24-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.06.014"},{"key":"bibr25-17151635231176270","unstructured":"ABORT73.COM. Australian abortion statistics; 2021. Available: https:\/\/abort73.com\/abortion_facts\/australian_abortion_statistics\/ (accessed Jun. 28, 2022)."},{"key":"bibr26-17151635231176270","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51217"},{"key":"bibr27-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2010.10.005"},{"key":"bibr28-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2021.03.022"},{"key":"bibr29-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004312"},{"key":"bibr30-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160581"},{"key":"bibr31-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9982-1"},{"key":"bibr32-17151635231176270","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.12705"}],"container-title":["Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17151635231176270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17151635231176270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17151635231176270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:06:59Z","timestamp":1772834819000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/17151635231176270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1177\/17151635231176270"],"URL":"https:\/\/doi.org\/10.1177\/17151635231176270","relation":{},"ISSN":["1715-1635","1913-701X"],"issn-type":[{"value":"1715-1635","type":"print"},{"value":"1913-701X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}